OFFICE OF CLINICAL RESEARCH EDUCATION AND COLLABORATION OUTREACH
Bench-to-Bedside and Back Program (BtB)
1999 Bench-to-Bedside and Back Program (BtB) Funded Projects
| Project | Institute or institution/Investigators | 
|---|---|
| Pretargeted Therapy of Epithelial Cancers with Radiolabeled Monoclonal Antibody B3 | NCI: Pastan, Ira CC: Carrasquillo, J.  | 
              
| Gene Therapy for X-Linked Severe Combined Immunodeficiency | NHGRI: Puck, J. NIAID: Malech, Harry  | 
              
| Vasculogenesis Using Progenitor Cells | NHLBI: Quyyumi, Arshed Ali; Finkel, Toren | 
| Evaluation of Therapeutic Reduction of Raised Elastase Levels by Reducing Neutrophil Numbers or by Direct Anti-Elastase | NIDCR: Wahl, Sharon NINR: Wysocki, Annette  | 
              
| Gene Therapy for Chronic Cancer and Arthritic Pain | NIDCR: Iadarola, Michael; Dionne, A. NIAMS: Kippel, J.  | 
              
| Development of Novel Therapies for Sickle Cell Disease | NIDDK: Schecter, Alan NCI: Keefer, Larry CC: Ognibene, Fred  | 
              
| Production of Clinical Grade ITX to Perform Clinical Trials for Treatment of Muscle Spasm Disorders (e.g., Torticollis and Blepharospasm) at NIH | NINDS: Youle, Richard; Hallet, Mark | 
| 
                   Study of the Effect of the Humanized Monoclonal Antibody Against the Interleukin-2 Receptor alpha Subunit (IL-R_;ZenapaxR) on Inflammatory Activity in the Central Nervous System in Multiple Sclerosis in a Baseline-to-Treatment, Cross-Over, MRI-Controlled Single-Center Phase I/II Trial  | 
                NINDS: Martin, R.; McFarland, Henry NCI: Waldmann, Thomas  | 
              


Social Media Links